www.fdanews.com/articles/75443-fda-approves-paroxetine-hcl-tablets
FDA APPROVES PAROXETINE HCL TABLETS
August 16, 2005
Teva Pharmaceutical announced that the FDA has granted final approval for Paroxetine HCl tablets, 10 mg, 20 mg, 30 mg and 40 mg. Teva's Paroxetine HCl tablets are the AB-rated generic equivalent of GlaxoSmithKline's antidepressant Paxil tablets.
Teva said shipment of this product would begin immediately. The HCl tablets are the AB-rated generic equivalent of GlaxoSmithKline's antidepressant Paxil tablets.